MMP24 as a Target of YAP is a Potential Prognostic Factor in Cancer Patients

The extracellular matrix (ECM) surrounding cancer cells becomes stiffer during tumor progression, which influences cancer cell behaviors such as invasion and proliferation through modulation of gene expression as well as remodeling of the actin cytoskeleton. In this study, we show that <i>MMP2...

Full description

Bibliographic Details
Main Authors: Wataru Sugimoto, Katsuhiko Itoh, Hiroaki Hirata, Yoshinori Abe, Takeru Torii, Yasumasa Mitsui, Yemima Budirahardja, Nobuyuki Tanaka, Keiko Kawauchi
Format: Article
Language:English
Published: MDPI AG 2020-02-01
Series:Bioengineering
Subjects:
Online Access:https://www.mdpi.com/2306-5354/7/1/18
_version_ 1827835091977502720
author Wataru Sugimoto
Katsuhiko Itoh
Hiroaki Hirata
Yoshinori Abe
Takeru Torii
Yasumasa Mitsui
Yemima Budirahardja
Nobuyuki Tanaka
Keiko Kawauchi
author_facet Wataru Sugimoto
Katsuhiko Itoh
Hiroaki Hirata
Yoshinori Abe
Takeru Torii
Yasumasa Mitsui
Yemima Budirahardja
Nobuyuki Tanaka
Keiko Kawauchi
author_sort Wataru Sugimoto
collection DOAJ
description The extracellular matrix (ECM) surrounding cancer cells becomes stiffer during tumor progression, which influences cancer cell behaviors such as invasion and proliferation through modulation of gene expression as well as remodeling of the actin cytoskeleton. In this study, we show that <i>MMP24</i> encoding matrix metalloproteinase (MMP)-24 is a novel target gene of Yes-associated protein (YAP), a transcription coactivator known as a mechanotransducer. We first examined the effect of substrate stiffness on <i>MMP24</i> expression in MCF-7 human breast cancer cells and showed that the expression of <i>MMP24</i> was significantly higher in cells grown on stiff substrates than that on soft substrates. The <i>MMP24</i> expression was significantly reduced by knockdown of YAP. In contrast, the expression of constitutively active YAP increased <i>MMP24</i> promoter activity. In addition, binding of YAP to the <i>MMP24</i> promoter was confirmed by the chromatin immunoprecipitation (ChIP) assay. These results show that ECM stiffening promotes YAP activation, thereby inducing <i>MMP24</i> expression. Based on the Human Protein Atlas database, breast cancer patients with lower <i>MMP24</i> expression exhibit the worse survival rates overall. Thus, <i>MMP24</i> may negatively regulate the aggressiveness of cancer cells under the stiff ECM environment during tumor progression.
first_indexed 2024-03-12T06:02:38Z
format Article
id doaj.art-3e951c9679464b00ba42ba075d2f8601
institution Directory Open Access Journal
issn 2306-5354
language English
last_indexed 2024-03-12T06:02:38Z
publishDate 2020-02-01
publisher MDPI AG
record_format Article
series Bioengineering
spelling doaj.art-3e951c9679464b00ba42ba075d2f86012023-09-03T04:00:33ZengMDPI AGBioengineering2306-53542020-02-01711810.3390/bioengineering7010018bioengineering7010018MMP24 as a Target of YAP is a Potential Prognostic Factor in Cancer PatientsWataru Sugimoto0Katsuhiko Itoh1Hiroaki Hirata2Yoshinori Abe3Takeru Torii4Yasumasa Mitsui5Yemima Budirahardja6Nobuyuki Tanaka7Keiko Kawauchi8Frontiers of Innovative Research in Science and Technology, Konan University, Kobe 650-0047, JapanFrontiers of Innovative Research in Science and Technology, Konan University, Kobe 650-0047, JapanMechanobiology Laboratory, Nagoya University Graduate School of Medicine, Nagoya 466-8550, JapanDepartment of Molecular Oncology, Institute for Advanced Medical Sciences, Nippon Medical School, Tokyo 113-0033, JapanFrontiers of Innovative Research in Science and Technology, Konan University, Kobe 650-0047, JapanFrontiers of Innovative Research in Science and Technology, Konan University, Kobe 650-0047, JapanFrontiers of Innovative Research in Science and Technology, Konan University, Kobe 650-0047, JapanDepartment of Molecular Oncology, Institute for Advanced Medical Sciences, Nippon Medical School, Tokyo 113-0033, JapanFrontiers of Innovative Research in Science and Technology, Konan University, Kobe 650-0047, JapanThe extracellular matrix (ECM) surrounding cancer cells becomes stiffer during tumor progression, which influences cancer cell behaviors such as invasion and proliferation through modulation of gene expression as well as remodeling of the actin cytoskeleton. In this study, we show that <i>MMP24</i> encoding matrix metalloproteinase (MMP)-24 is a novel target gene of Yes-associated protein (YAP), a transcription coactivator known as a mechanotransducer. We first examined the effect of substrate stiffness on <i>MMP24</i> expression in MCF-7 human breast cancer cells and showed that the expression of <i>MMP24</i> was significantly higher in cells grown on stiff substrates than that on soft substrates. The <i>MMP24</i> expression was significantly reduced by knockdown of YAP. In contrast, the expression of constitutively active YAP increased <i>MMP24</i> promoter activity. In addition, binding of YAP to the <i>MMP24</i> promoter was confirmed by the chromatin immunoprecipitation (ChIP) assay. These results show that ECM stiffening promotes YAP activation, thereby inducing <i>MMP24</i> expression. Based on the Human Protein Atlas database, breast cancer patients with lower <i>MMP24</i> expression exhibit the worse survival rates overall. Thus, <i>MMP24</i> may negatively regulate the aggressiveness of cancer cells under the stiff ECM environment during tumor progression.https://www.mdpi.com/2306-5354/7/1/18mmpyapecmmechanical signal transductioncancer progressionprognosis
spellingShingle Wataru Sugimoto
Katsuhiko Itoh
Hiroaki Hirata
Yoshinori Abe
Takeru Torii
Yasumasa Mitsui
Yemima Budirahardja
Nobuyuki Tanaka
Keiko Kawauchi
MMP24 as a Target of YAP is a Potential Prognostic Factor in Cancer Patients
Bioengineering
mmp
yap
ecm
mechanical signal transduction
cancer progression
prognosis
title MMP24 as a Target of YAP is a Potential Prognostic Factor in Cancer Patients
title_full MMP24 as a Target of YAP is a Potential Prognostic Factor in Cancer Patients
title_fullStr MMP24 as a Target of YAP is a Potential Prognostic Factor in Cancer Patients
title_full_unstemmed MMP24 as a Target of YAP is a Potential Prognostic Factor in Cancer Patients
title_short MMP24 as a Target of YAP is a Potential Prognostic Factor in Cancer Patients
title_sort mmp24 as a target of yap is a potential prognostic factor in cancer patients
topic mmp
yap
ecm
mechanical signal transduction
cancer progression
prognosis
url https://www.mdpi.com/2306-5354/7/1/18
work_keys_str_mv AT watarusugimoto mmp24asatargetofyapisapotentialprognosticfactorincancerpatients
AT katsuhikoitoh mmp24asatargetofyapisapotentialprognosticfactorincancerpatients
AT hiroakihirata mmp24asatargetofyapisapotentialprognosticfactorincancerpatients
AT yoshinoriabe mmp24asatargetofyapisapotentialprognosticfactorincancerpatients
AT takerutorii mmp24asatargetofyapisapotentialprognosticfactorincancerpatients
AT yasumasamitsui mmp24asatargetofyapisapotentialprognosticfactorincancerpatients
AT yemimabudirahardja mmp24asatargetofyapisapotentialprognosticfactorincancerpatients
AT nobuyukitanaka mmp24asatargetofyapisapotentialprognosticfactorincancerpatients
AT keikokawauchi mmp24asatargetofyapisapotentialprognosticfactorincancerpatients